Indefinite Delivery Contract SPE2DR25D9942

The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical supply needs of military health facilities worldwide.

The IDC, which runs through December 2036, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract is part of DLA's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish multiple regional prime vendor contracts valued at an estimated $30.3 billion to provide worldwide pharmaceutical support to DoD customers, the U.S. Coast Guard, and other government agencies. The PPV-G GEN V solicitation is expected to be issued in March 2024 with a 45-day open period, and the government intends to make multiple regional awards with at least three different contractors selected.